Jan 23 (Reuters) - Shenzhen Kangtai Biological Products Co Ltd
* Says it and wholly owned biotechnology unit get clinical trial approval for its injection, which will be used for treatment of hand-foot-and-mouth disease
Source text in Chinese: goo.gl/73rxD5
Further company coverage: (Beijing Headline News)
 